Nexalis Therapeutics LimitedASX: NX1

IRX211 - Targeted Pain Indication Nomination - BTcP

Jan 10, 2024 at 5:52 AM UTC · Issued by Nexalis Therapeutics Limited

Nexalis Therapeutics Limited has released a press release.

View Attachment